About company
Educational Scientific and Production Republican Unitary Enterprise “UNITEHPROM BSU” was established on September 30, 1999 by order of the rector of BSU to introduce scientific developments of scientists of BSU: “from a scientific idea to the organization of production and release of innovative products”.
The UE “UNITEHPROM BSU” is an innovative science production enterprise with the status of a science and technology park. The company develops and implements in the production of medicinal products and pharmaceutical substances, modern chemical-analytical and special technologies, the production of measuring equipment, medical devices.
April 20, 2016, the company is received accreditation as a scientific organization.
On September 10, 2017, a certificate of registration of the enterprise as a scientific and technological park was issued.
Since 2019, it has been a full member of the Belarusian Chamber of Commerce and Industry.
Main approaches of activities
The types of activities and products of the enterprise
Industrial production and wholesale sale of pharmaceutical substances and original anticancer medicines for local chemotherapy: “Cisplacel”, “Temodex”. Pharmaceutical activity license № 02040/882. The production of pharmaceutical products is carried out under the requirements of Good Manufacturing Practice (GMP) № 126/2019/GMP.
Development and production of computer-oriented measuring systems, optoelectronic assemblies and devices, electronic components for flight data recording systems, souvenir electronic products, electronic components of small spacecraft, diagnostic systems of mechanisms and machines, monitoring devices for mobile objects, educational laboratory units, medical electronics products, medical equipment spirometers MAS-1-A and MAS-1-PC.
Development and production of ingredients for the food industry: technological and enrichment additives, vitamin and mineral complexes, gluten-free mixtures for the baking industry, phytosalts, dry seasonings, compositions for beverages, lubricants for baking molds, fertilizers.
Development and production of flight information rewriting equipment for aircraft and software for working with digital information streams.
Production of reagent kits for staining blood smears (for devices such as “Hemo-Tek”, “AvtoOMK-1”), production of reagent kits for biochemical blood tests, a complete set of solutions for hematological analyzers “Hemacomp-10” by SEAC (Italy) - isotonic, lysing, deproteinizing solutions, detergent.
Production is carried out under the requirements of № 126/2019/GMP, HACCP, ISO 13485:2016.
Pharmacovigilance
Today, thanks to modern medicines, many previously incurable diseases are amenable to successful therapy, allowing patients to restore their health and maintain public health at a high level. However, despite these advantages, the medical use of drugs is always associated with a certain risk of adverse reactions.
UE “UNITEHPROM BSU” attaches great importance to the quality of products and issues of their safety, therefore, taking care of the health of consumers of our medicines is one of the leading activities of the enterprise. The UE “UNITEHPROM BSU” has developed and implemented a pharmacovigilance system under TCP 564-2015 (Good Pharmacovigilance Practice).
Pharmacovigilance is a type of activity aimed at identifying, assessing, understanding, and preventing undesirable consequences of the use of medicines.
In order to prevent undesirable consequences when using medicines produced by UE “UNITEHPROM BSU”, your support is crucial, regardless of whether you are a patient or a healthcare professional.
If you have developed an adverse reaction while using our medicines, please fill out the form below or report in a convenient format to the following address:
220045, Republic of Belarus, Minsk, Kurchatova str. 1
Contact phone: +375 (17) 209-59-33
Adverse drug reaction report
Consumer form
| Form for specialists |
Innovative projects
We develop our products according to the full innovation cycle: from the formulation of the technical specification to mass production. Together with the Research Institute of the Physical and Chemical Problem BSU, within the framework of the State Program for the Pharmaceutical Industry Development of the Republic of Belarus (2016-2020), tasks are being implemented to develop technology and organize the production of original medicines “Foscelantan”, “Antispike”, “Prospidelong”. We have 5 patents of the Republic of Belarus and the Russian Federation, 2 Patents of the Eurasian Economic Union.
An innovative project of the Innovative Development State Program of the Republic of Belarus “Creation of low-tonnage production of pharmaceutical substances for the production of antitumor, cardiotropic and other medicines conforming to GMP standards based on organizations of the Ministry of Education” has been implemented, within which a site for the production of original medicines “Cisplacel”, “Temodex” for local chemotherapy of malignant brain tumors and tumors in the head and neck area has been created. Production sites of generic pharmaceutical substances “Temozolomide”, “Prospidium Chloride” have been created for the production of antitumor medicines and original pharmaceutical substances “Temodex”, “Prospidelong” and “Nitargal”.
As part of the Innovative Development State Program, an innovative project is being implemented “Organization of production of original bioresorbable multifunctional medicines” under GMP requirements. Implementation period 2019-2022.
Full innovation cycle
Products are developed in a complete innovation cycle, from the formulation of technical specifications to mass production. Together with the Scientific Research Institute of Pharmaceutical Chemistry, BSU, within the framework of the State Program for the Development of the Pharmaceutical Industry of the Republic of Belarus (2016-2020), tasks are carried out to develop the technology and organize the production of original medicines Fosfalantan, Antispike, Prospidelong. 5 patents of the Republic of Belarus and the Russian Federation, 2 patents of the Eurasian Economic Community.